The store will not work correctly when cookies are disabled.
N'-(2-Hydroxy-3-methoxybenzoyl)-2-oxo-2H-chromene-3-carbohydrazide
ID: ALA4589409
PubChem CID: 146000282
Max Phase: Preclinical
Molecular Formula: C18H14N2O6
Molecular Weight: 354.32
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cccc(C(=O)NNC(=O)c2cc3ccccc3oc2=O)c1O
Standard InChI: InChI=1S/C18H14N2O6/c1-25-14-8-4-6-11(15(14)21)16(22)19-20-17(23)12-9-10-5-2-3-7-13(10)26-18(12)24/h2-9,21H,1H3,(H,19,22)(H,20,23)
Standard InChI Key: DHFQWWJABQBHOS-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
3.9648 -22.7245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9637 -23.5440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6717 -23.9530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6700 -22.3156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3786 -22.7209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3774 -23.5461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0875 -23.9574 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.8033 -23.5481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8045 -22.7229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0899 -22.3070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5099 -23.9587 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.5132 -22.3161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2199 -22.7264 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5152 -21.4989 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.9286 -22.3195 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.6353 -22.7299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3440 -22.3230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6333 -23.5470 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.0471 -22.7358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7554 -22.3296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7578 -21.5116 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0461 -21.1014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3408 -21.5099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0430 -23.5530 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.4619 -22.7403 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.1708 -22.3338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
8 11 2 0
9 12 1 0
12 13 1 0
12 14 2 0
13 15 1 0
15 16 1 0
16 17 1 0
16 18 2 0
17 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 17 1 0
19 24 1 0
20 25 1 0
25 26 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 354.32 | Molecular Weight (Monoisotopic): 354.0852 | AlogP: 1.58 | #Rotatable Bonds: 3 |
Polar Surface Area: 117.87 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.37 | CX Basic pKa: ┄ | CX LogP: 2.02 | CX LogD: 1.98 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.49 | Np Likeness Score: -0.64 |
References
1. Jesumoroti OJ, Faridoon, Mnkandhla D, Isaacs M, Hoppe HC, Klein R.. (2019) Evaluation of novel N'-(3-hydroxybenzoyl)-2-oxo-2H-chromene-3-carbohydrazide derivatives as potential HIV-1 integrase inhibitors., 10 (1): [PMID:30774857] [10.1039/C8MD00328A] |